Medtronic plc — Director's Dealing 2024

Aug 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2024-07-29

Reporting Person: Salmon Sean (EVP & President Cardiovascular)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-29	Ordinary Shares	A	14375	—	Acquired	63084	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-29	Performance Share Unit	$	A	35938	Acquired		Performance Share Units (35938)	Direct
2024-07-29	Stock Option (Right to Buy)	$80	A	106260	Acquired	2034-07-29	Ordinary Shares (106260)	Direct

Footnotes

F1: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2: Includes 420 shares acquired through dividend reinvestment since the last report filed by the reporting person.

F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4: Vests on July 29, 2027.

F5: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,938 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F6: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.